ModelEdge
Retension Pharmaceuticals, Inc.
0002002988
Filing type
S-1/A
Filing date
Oct 4, 2026
Updated
Oct 5, 2026 ยท 5:23 AM

Filing

S-1/AAmended Registration Statement for Securities

Exhibits

EX-1.1FORM OF UNDERWRITING AGREEMENTEX-3.2CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF THE COMPANY, EFFECTING A REVERSE STOCK SPLIT, EFFECTIVE AS OF OCTOBER 2, 2026EX-5.1OPINION OF DLA PIPER LLP (US)EX-10.4RETENSION PHARMACEUTICALS, INC. 2026 EQUITY INCENTIVE PLANEX-10.5RETENSION PHARMACEUTICALS, INC. 2026 EMPLOYEE STOCK PURCHASE PLANEX-10.8OFFER OF EMPLOYMENT, DATED AUGUST 14, 2026, BY AND BETWEEN THE COMPANY AND ERIC KELLEREX-10.26CONSULTING AGREEMENTEX-10.27CONSULTING AGREEMENTEX-23.1CONSENT OF WOLF & COMPANY, P.C.EX-FILING FEESFILING FEE TABLEGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphic